上海新陽(300236.SZ):擬出資1億元參設創投基金新潮萬芯
格隆匯4月6日丨上海新陽(300236.SZ)公佈,為提高公司的資金盈利能力,挖掘潛在投資機會,公司擬以自有資金參與江蘇新潮創新投資集團私募基金管理有限公司(簡稱“新潮創新”)發起設立的投資基金,基金名稱為江蘇新潮萬芯創業投資合夥企業(有限合夥)(簡稱“新潮萬芯”,以工商部門最終核定為準),
新潮萬芯基金初始募集規模3.135億元,普通合夥人及基金管理人為新潮創新。公司認繳人民幣1億元作為有限合夥人。截至該公吿日,公司尚未實繳出資。新潮萬芯將通過基金業協會認可的股權形式投資半導體及泛半導體領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.